63 related articles for article (PubMed ID: 20863649)
21. Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications.
Negredo E; Massanella M; Puig J; Pérez-Alvarez N; Gallego-Escuredo JM; Villarroya J; Villarroya F; Moltó J; Santos JR; Clotet B; Blanco J
Clin Infect Dis; 2010 May; 50(9):1300-8. PubMed ID: 20367229
[TBL] [Abstract][Full Text] [Related]
22. Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution.
Blankson JN; Gallant JE; Siliciano RF
J Infect Dis; 2001 Feb; 183(4):657-61. PubMed ID: 11170994
[TBL] [Abstract][Full Text] [Related]
23. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M;
Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216
[TBL] [Abstract][Full Text] [Related]
24. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
Moore RD; Keruly JC
Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
[TBL] [Abstract][Full Text] [Related]
25. Opportunistic infection as a cause of transient viremia in chronically infected HIV patients under treatment with HAART.
Jones LE; Perelson AS
Bull Math Biol; 2005 Nov; 67(6):1227-51. PubMed ID: 16023709
[TBL] [Abstract][Full Text] [Related]
26. Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: a cross-sectional evaluation.
Bonora S; Nicastri E; Calcagno A; Gonzalez de Requena D; D'Ettorre G; Sarmati L; Palmisano L; Vullo V; Di Perri G; Andreoni M
J Med Virol; 2009 Mar; 81(3):400-5. PubMed ID: 19152404
[TBL] [Abstract][Full Text] [Related]
27. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
Isgrò A; Leti W; De Santis W; Marziali M; Esposito A; Fimiani C; Luzi G; Pinti M; Cossarizza A; Aiuti F; Mezzaroma I
Clin Infect Dis; 2008 Jun; 46(12):1902-10. PubMed ID: 18462177
[TBL] [Abstract][Full Text] [Related]
28. A significant proportion of HIV-infected patients admitted to hospital have immunosuppression as a result of failure of highly active antiretroviral therapy.
Manavi K; McMillan A
HIV Med; 2004 Sep; 5(5):360-3. PubMed ID: 15369511
[TBL] [Abstract][Full Text] [Related]
29. Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART.
Collazos J; Asensi V; Cartón JA
AIDS; 2007 Apr; 21(7):835-43. PubMed ID: 17415038
[TBL] [Abstract][Full Text] [Related]
30. Impact of baseline CD4(+) T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study.
Liu ZY; Guo FP; Han Y; Qiu ZF; Zuo LY; Li YL; Li TS
Chin Med J (Engl); 2009 Oct; 122(20):2497-502. PubMed ID: 20079166
[TBL] [Abstract][Full Text] [Related]
31. Autologous CCR5-modified CD4 T-cells effective in HAART nonresponders.
AIDS Patient Care STDS; 2011 Nov; 25(11):693. PubMed ID: 22132424
[No Abstract] [Full Text] [Related]
32. Polyactin A can increase CD4+T cell counts in HIV-infected individuals with insufficient immunologic response to HAART: is it a reality?
Li Q; Zhang L; Yang J; Liu Z
Int J STD AIDS; 2014 Nov; 25(13):975. PubMed ID: 25318857
[No Abstract] [Full Text] [Related]
33. Early correction of cell cycle perturbations predicts the immunological response to therapy in HIV-infected patients.
Paiardini M; Cervasi B; Galati D; Dominici S; Albrecht H; Sfacteria A; Magnani M; Silvestri G; Piedimonte G
AIDS; 2004 Feb; 18(3):393-402. PubMed ID: 15090790
[TBL] [Abstract][Full Text] [Related]
34. CD4+ T cell recovery with antiretroviral therapy: more than the sum of the parts.
Geng EH; Deeks SG
Clin Infect Dis; 2009 Feb; 48(3):362-4. PubMed ID: 19123869
[No Abstract] [Full Text] [Related]
35. Acute dialysis in HIV-positive patients in Cape Town, South Africa.
Arendse C; Okpechi I; Swanepoel C
Nephrology (Carlton); 2011 Jan; 16(1):39-44. PubMed ID: 21175975
[TBL] [Abstract][Full Text] [Related]
36. Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy.
Tumbarello M; Rabagliati R; de Gaetano Donati K; Bertagnolio S; Montuori E; Tamburrini E; Tacconelli E; Cauda R
BMC Infect Dis; 2004 Nov; 4():46. PubMed ID: 15530169
[TBL] [Abstract][Full Text] [Related]
37. Cohort study of diabetes in HIV-infected adult patients: evaluating the effect of diabetes mellitus on immune reconstitution.
Moyo D; Tanthuma G; Cary MS; Mushisha O; Kwadiba G; Chikuse F; Steenhoff AP; Reid MJ
Diabetes Res Clin Pract; 2014 Mar; 103(3):e34-6. PubMed ID: 24485344
[TBL] [Abstract][Full Text] [Related]
38. Delayed-type hypersensitivity skin testing can predict CD4 count increase in HIV patients with poor immunologic response to HAART.
Meroni L; Marchetti G; Gatti N; Monforte Ad; Galli M
J Acquir Immune Defic Syndr; 2003 Jun; 33(2):277-8. PubMed ID: 12794567
[No Abstract] [Full Text] [Related]
39. The challenge of IL-2 immunotherapy in HIV disease: "no through road" or turning point?
Marchetti G; Tincati C; Monforte Ad; Gori A
Curr HIV Res; 2008 May; 6(3):189-99. PubMed ID: 18473782
[TBL] [Abstract][Full Text] [Related]
40. A case-control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced age.
Manfredi R; Chiodo F
AIDS; 2000 Jul; 14(10):1475-7. PubMed ID: 10930176
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
